Dose-Normalised Time in Range (dn-TIR) Improves Following Hybrid Closed-Loop (HCL) Therapy in Type 1 Diabetes: A Real-World Cohort Study From Australia and the United Kingdom.
- DOI
- 10.1111/dom.71342
- Published
- 2026 Sep 9
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.71342,
title = {Dose-Normalised Time in Range (dn-TIR) Improves Following Hybrid Closed-Loop (HCL) Therapy in Type 1 Diabetes: A Real-World Cohort Study From Australia and the United Kingdom.},
author = {Wellens-Mensah J and Konantambigi A and Lopez K and Triay J and Shenoy V and Puri G and Wilmot E and Sathyapalan T and Deshmukh H},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.71342},
url = {https://doi.org/10.1111/dom.71342}
}RIS
TY - JOUR TI - Dose-Normalised Time in Range (dn-TIR) Improves Following Hybrid Closed-Loop (HCL) Therapy in Type 1 Diabetes: A Real-World Cohort Study From Australia and the United Kingdom. AU - Wellens-Mensah J AU - Konantambigi A AU - Lopez K AU - Triay J AU - Shenoy V AU - Puri G AU - Wilmot E AU - Sathyapalan T AU - Deshmukh H PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.71342 UR - https://doi.org/10.1111/dom.71342 ER -
APA
J, W., A, K., K, L., J, T., V, S., G, P., E, W., T, S., & H, D. (2026). Dose-Normalised Time in Range (dn-TIR) Improves Following Hybrid Closed-Loop (HCL) Therapy in Type 1 Diabetes: A Real-World Cohort Study From Australia and the United Kingdom.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71342
Source records
- pubmed · retrieved 2026-09-25T17:45:24.064Z
- europe-pmc · retrieved 2026-09-25T17:45:24.097Z